Skip to main content
Livermore
Livermore
ZHEN

Vanguard Group Inc

SEC CIK
0000102909
Latest filing
Jan 29, 2026

RAPT holding history

RAPT Therapeutics, Inc. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RAPT overviewAll 13F holders of RAPTFull Q4 2025 holdings

Shares (Q4 2025)
1,186,791
Value
$40.2M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of RAPT by Vanguard Group Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20251,186,791$40.2M<0.1%+490,603+70.5%AddedHolders
Q3 2025696,188$18.0M<0.1%−183,861−20.9%ReducedHolders
Q2 2025880,049$7.04M<0.1%−7,398,749−89.4%ReducedHolders
Q1 20258,278,798$10.1M<0.1%+5,337,449+181.5%AddedHolders
Q4 20242,941,349$4.65M<0.1%−214,656−6.8%ReducedHolders
Q3 20243,156,005$6.34M<0.1%+47,737+1.5%AddedHolders
Q2 20243,108,268$9.48M<0.1%+615,418+24.7%AddedHolders
Q1 20242,492,850$22.4M<0.1%+436,629+21.2%AddedHolders
Q4 20232,056,221$51.1M<0.1%+32,916+1.6%AddedHolders
Q3 20232,023,305$33.6M<0.1%+76,356+3.9%AddedHolders
Q2 20231,946,949$36.4M<0.1%+365,431+23.1%AddedHolders
Q1 20231,581,518$29.0M<0.1%+74,345+4.9%AddedHolders
Q4 20221,507,173$29.8M<0.1%+223,265+17.4%AddedHolders
Q3 20221,283,908$30.9M<0.1%+18,363+1.5%AddedHolders
Q2 20221,265,545$23.1M<0.1%+41,000+3.3%AddedHolders
Q1 20221,224,545$26.9M<0.1%+18,193+1.5%AddedHolders
Q4 20211,206,352$44.3M<0.1%+127,466+11.8%AddedHolders
Q3 20211,078,886$33.5M<0.1%+164,970+18.1%AddedHolders
Q2 2021913,916$29.1M<0.1%+162,516+21.6%AddedHolders
Q1 2021751,400$16.7M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.